Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 281 Specimen Handling 271 pembrolizumab 253 Cyclophosphamide 235 Radiotherapy 227 Nivolumab 184 Cisplatin 172 Biopsy 161 Carboplatin 155 Radiosurgery 143 fludarabine 131 Blood Specimen Collection 129 Surveys and Questionnaires 120 Gemcitabine 119 Paclitaxel 116 venetoclax 114 Standard of Care 112 Dexamethasone 107 Bevacizumab 93 Radiation 92 Rituximab 91 Oxaliplatin 89 Cytarabine 88 Ipilimumab 84 Drug Therapy 84 Capecitabine 84 Doxorubicin 81 durvalumab 80 fludarabine phosphate 73 Fluorouracil 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × penpulimab × 90 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡